Press Release

Precision Diagnostics Market to Grow at 16.48% CAGR through 2029F

Rising incidences of chronic diseases and expansion of point-of-care testing (POCT) is expected to drive the Global Precision Diagnostics Market growth in the forecast period, 2025-2029.


According to TechSci Research report, “Precision Diagnostics Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2019-2029F”, the Global Precision Diagnostics Market stood at USD 14.18 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 16.48% through 2029.


Precision diagnostics have emerged as a cornerstone in modern healthcare, offering tailored diagnostic and treatment solutions that enhance patient outcomes and optimize healthcare delivery. The intersection of precision diagnostics with digital health technologies represents a transformative leap forward in healthcare delivery, enhancing the ability to monitor, diagnose, and treat patients more effectively and efficiently. Key digital health innovations such as wearable devices, remote patient monitoring systems, and mobile health applications are reshaping clinical practices by enabling continuous, real-time data collection and analysis.

Wearable biosensors are at the forefront of this revolution, offering capabilities beyond traditional healthcare settings. These devices can monitor various physiological parameters, including heart rate variability, oxygen saturation levels, and even biochemical markers like glucose levels. For diabetic patients, continuous glucose monitoring (CGM) systems provide clinicians with detailed insights into glucose fluctuations throughout the day, facilitating personalized insulin dosing adjustments and dietary recommendations. Such real-time data not only improves disease management but also empowers patients to make informed decisions about their health.


Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Precision Diagnostics Market


Remote patient monitoring systems extend healthcare beyond hospital walls, allowing healthcare providers to remotely monitor patients' vital signs and health metrics from their homes. This is particularly beneficial for chronic disease management, where regular monitoring of blood pressure, heart rhythms, and medication adherence can prevent complications and reduce hospitalizations. AI-powered algorithms analyze incoming data, flagging deviations from baseline and alerting healthcare teams to potential issues early, enabling timely interventions and proactive care.

Mobile health applications complement these technologies by providing patients with personalized health coaching, medication reminders, and access to their health records. Patients can actively participate in their care management, track their progress, and communicate securely with healthcare providers, promoting engagement and treatment adherence.

The integration of precision diagnostics with digital health not only enhances patient outcomes but also optimizes healthcare resource allocation. By reducing unnecessary clinic visits, preventing hospital admissions, and enabling more targeted interventions, these technologies contribute to cost savings and operational efficiencies within healthcare systems.

The Global Precision Diagnostics Market is segmented into Type, application, End-Use, regional distribution, and company. 

Based on application, In 2023 in the global precision diagnostics market, oncology emerged as the dominant segment. This leadership position is primarily driven by the increasing prevalence of cancer worldwide and the critical role of precision diagnostics in improving cancer detection, treatment selection, and patient outcomes. Precision diagnostics in oncology involve advanced molecular profiling techniques such as next-generation sequencing (NGS), liquid biopsies, and biomarker analysis. These technologies enable oncologists to identify specific genetic mutations, biomarkers, and molecular signatures associated with different types of cancer. Such insights are instrumental in guiding personalized treatment strategies, including targeted therapies and immunotherapies, which can effectively inhibit cancer progression while minimizing side effects. The advent of companion diagnostics has significantly bolstered the oncology segment within precision diagnostics. Companion diagnostics are tests that identify biomarkers or genetic mutations that predict a patient's response to a specific therapy. They play a crucial role in determining which patients are likely to benefit from targeted therapies, thereby optimizing treatment efficacy and patient outcomes. The prominence of oncology in the precision diagnostics market is further underscored by ongoing research and development efforts aimed at expanding the repertoire of biomarkers and therapeutic targets. As molecular understanding of cancer continues to deepen and technology advances, oncology-focused precision diagnostics are expected to continue driving innovation and market growth in the years ahead, contributing to more personalized and effective cancer care globally.

Based on region, after North America, Europe emerges as the second dominating region in the Global Precision Diagnostics Market. Europe's strong position is attributed to several factors contributing to its significant market share. The region benefits from advanced healthcare systems, well-established clinical research capabilities, and a high level of healthcare expenditure, fostering the adoption of precision diagnostics. Regulatory bodies such as the European Medicines Agency (EMA) ensure stringent but transparent approval processes for new diagnostic technologies, supporting innovation and market entry. Moreover, Europe's proactive approach towards healthcare policies emphasizes personalized medicine and genomic research, driving the demand for precision diagnostics that cater to individual patient needs. Collaborative efforts between academia, healthcare institutions, and industry players further promote technological advancements and the integration of precision diagnostics into clinical practice. These factors collectively position Europe as a key player in the global precision diagnostics market, facilitating continued growth and innovation in healthcare delivery.


Major companies operating in Global Precision Diagnostics Market are:

  • Abbott Laboratories Inc.
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Hologic Inc.
  • Agilent Technologies Inc


Download Free Sample Report

Customers can also request for 10% free customization on this report


“The expansion of point-of-care testing (POCT) represents another pivotal trend shaping the precision diagnostics market. POCT devices enable rapid on-site diagnostic testing, delivering results within minutes to hours directly at the patient's location, whether in a hospital, clinic, or even at home. This immediacy is particularly advantageous in emergency settings, rural areas with limited access to centralized laboratories, and for monitoring chronic conditions in outpatient settings. Technological advancements have miniaturized diagnostic tools and enhanced their accuracy, sensitivity, and multiplexing capabilities, enabling comprehensive testing for a wide range of conditions at the point of care. For instance, handheld devices using molecular techniques like PCR or isothermal amplification can diagnose infectious diseases such as COVID-19 or influenza swiftly, guiding timely treatment decisions and infection control measures. The growing demand for rapid and accurate diagnostic solutions, coupled with regulatory approvals facilitating broader adoption of POCT devices, is driving market growth in precision diagnostics.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

Precision Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Genetic Tests, Direct to Consumer Tests, Esoteric Tests, Others), By Application (Oncology, Respiratory Diseases, Skin Diseases, CNS Disorders, Immunology, Genetic Diseases, Others), By End-Use (Hospitals, Clinical Laboratories, Others), By Region and Competition, 2019-2029F”, has evaluated the future growth potential of Global Precision Diagnostics Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Precision Diagnostics Market.



TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]


Relevant News